Artivion, a medical device company that makes implantable tissues for heart and vascular transplant applications, said its services were “disrupted” due to a cybersecurity incident.
In an 8-K filing with the SEC on Monday, Georgia-based Artivion (formerly Cryolife) disclosed a “cybersecurity incident” involving the “capture and encryption” of data on Nov. 21. He said he recognized it. This suggests that the company has suffered damage. However, Artivion has not yet confirmed the nature of the incident and did not immediately respond to TechCrunch's questions. No major ransomware group has yet claimed responsibility for the attack.
Artivion said it took some systems offline in response to the cyberattack, which the company said caused “disruptions to some ordering and shipping processes.”
Artivion, which reported third-quarter sales of $95.8 million, said it does not expect the incident to have a material impact on its finances.